• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply

Welcome to the international HTA database

CSV RIS
Showing [22099 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2003     NIHR Health Technology Assessment programme Can randomised trials rely on existing electronic data? A feasibility study to explore the value of routine data in health technology assessment
2018     NIHR Health Technology Assessment programme Nicotine preloading for smoking cessation: the Preloading RCT
2016     NIHR Health Technology Assessment programme Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
2020     NIHR Health Technology Assessment programme Risk assessments and structured care interventions for prevention of foot ulceration in diabetes: development and validation of a prognostic model
1999     NIHR Health Technology Assessment programme Near patient testing in diabetes clinics: appraising the costs and outcomes
2000     NIHR Health Technology Assessment programme Early asthma prophylaxis, natural history, skeletal development and economy (EASE): a pilot randomised controlled trial
2003     NIHR Health Technology Assessment programme Evaluating non-randomised intervention studies
2009     NIHR Health Technology Assessment programme Development of a decision support tool for primary care management of patients with abnormal liver function tests without clinically apparent liver disease: a record-linkage population cohort study and decision analysis (ALFIE)
2006     NIHR Health Technology Assessment programme A systematic review and economic model of the clinical and cost-effectiveness of immunosuppressive therapy for renal transplantation in children
2007     NIHR Health Technology Assessment programme The effectiveness and cost-effectiveness of natalizumab for multiple sclerosis: an evidence review of the submission from Biogen
2019     NIHR Health Technology Assessment programme Manualised cognitive behavioural therapy in treating depression in advanced cancer: the CanTalk RCT
2013     NIHR Health Technology Assessment programme Faecal calprotectin testing for differentiating amongst inflammatory and non-inflammatory bowel diseases: a systematic review and economic evaluation
2015     NIHR Health Technology Assessment programme Behaviour change techniques: the development and evaluation of a taxonomic method for reporting and describing behaviour change interventions (a suite of five studies involving consensus methods, randomised controlled trials and analysis of qualitative data)
2020     NIHR Health Technology Assessment programme The Namaste Care intervention to improve the quality of dying for people with advanced dementia living in care homes: a realist review and feasibility study for a cluster randomised controlled trial
2000     NIHR Health Technology Assessment programme Screening for hypercholesterolaemia versus case finding for familial hypercholesterolaemia: a systematic review and cost-effectiveness analysis
2004     NIHR Health Technology Assessment programme Generalisability in economic evaluation studies in healthcare: a review and case studies
2012     NIHR Health Technology Assessment programme Managing Injuries of the Neck Trial (MINT): a randomised controlled trial of treatments for whiplash injuries
2006     NIHR Health Technology Assessment programme Amniocentesis results: investigation of anxiety. The ARIA trial.
2009     NIHR Health Technology Assessment programme Mifamurtide for osteosarcoma
2017     NIHR Health Technology Assessment programme Randomised controlled trial evaluating the effectiveness and cost-effectiveness of 'Families for Health', a family-based childhood obesity treatment intervention delivered in a community setting for ages 6 to 11 years
2013     NIHR Health Technology Assessment programme Clinical effectiveness and cost-effectiveness of second- and third-generation left ventricular assist devices as either bridge to transplant or alternative to transplant for adults eligible for heart transplantation: systematic review and cost-effectiveness model
2015     NIHR Health Technology Assessment programme Tonsillectomy or adenotonsillectomy versus non-surgical management for sleep-disordered breathing in children
2020     NIHR Health Technology Assessment programme Non-contact infrared thermometers for measuring body temperature in acutely ill children: a method comparison study
2021     NIHR Health Technology Assessment programme Universal late pregnancy ultrasound screening to predict adverse outcomes in nulliparous women: a systematic review and cost-effectiveness analysis
1998     NIHR Health Technology Assessment programme Resource allocation for chronic stable angina: a systematic review of effectiveness, costs and cost-effectiveness of alternative interventions
2004     NIHR Health Technology Assessment programme Virtual outreach: a randomised controlled trial and economic evaluation of joint teleconferenced medical consultations
2011     NIHR Health Technology Assessment programme Conservative treatment for urinary incontinence in Men After Prostate Surgery (MAPS): two parallel randomised controlled trials
2006     NIHR Health Technology Assessment programme Pemetrexed for the treatment of relapsed non-small cell lung cancer
2016     NIHR Health Technology Assessment programme Cognitive-behavioural therapy-based intervention to reduce fear of falling in older people: therapy development and randomised controlled trial - the Strategies for Increasing Independence, Confidence and Energy (STRIDE) study
2016     NIHR Health Technology Assessment programme The second Randomised Evaluation of the Effectiveness, cost-effectiveness and Acceptability of Computerised Therapy (REEACT-2) trial: does the provision of telephone support enhance the effectiveness of computer-delivered cognitive behaviour therapy? A randomised controlled trial
2015     NIHR Health Technology Assessment programme Interventions for the treatment of oral and oropharyngeal cancers: immunotherapy
2019     NIHR Health Technology Assessment programme Cabozantinib and vandatinib for treating advanced or metastatic medullary thyroid cancer (ID56)
1998     NIHR Health Technology Assessment programme Evaluating patient-based outcome measures for use in clinical trials: a review
1999     NIHR Health Technology Assessment programme The debridement of chronic wounds: a systematic review
2000     NIHR Health Technology Assessment programme Implantable cardioverter defibrillators: arrhythmias. A rapid and systematic review
2012     NIHR Health Technology Assessment programme Clinical effectiveness, cost-effectiveness and service users' perceptions of early, well-resourced communication therapy following a stroke: a randomised controlled trial (the ACT NoW Study)
2009     NIHR Health Technology Assessment programme Tocilizumab for the treatment of rheumatoid arthritis
2016     NIHR Health Technology Assessment programme Evaluating Acupuncture and Standard care for pregnant womEn with BACK pain (EASE BACK): a feasibility and pilot study
2014     NIHR Health Technology Assessment programme The clinical and cost-effectiveness of lenalidomide for people who have received at least one prior therapy with bortezomib (partial review of TA171)
2022     NIHR Health Technology Assessment programme The RAPID-CTCA trial (Rapid Assessment of Potential Ischaemic Heart Disease with CTCA) The role of early CT Coronary Angiography in the evaluation, intervention and outcome of patients presenting to the Emergency Department with suspected or confirmed Acute Coronary Syndrome
2021     NIHR Health Technology Assessment programme DISC: Dupuytren's Interventions Surgery vs. Collagenase. A pragmatic multi-centre randomised controlled non-inferiority, cost effectiveness trial comparing injections of collagenase into the cord to surgical correction in the treatment of moderate Dupuytren's contracture in adult patients
1999     NIHR Health Technology Assessment programme Antenatal and neonatal haemoglobinopathy screening in the UK: review and economic analysis
2000     NIHR Health Technology Assessment programme A randomised controlled trial of prehospital intravenous fluid replacement therapy in serious trauma
2004     NIHR Health Technology Assessment programme What is the best imaging strategy for acute stroke?
2015     NIHR Health Technology Assessment programme Computed tomographic colonography compared with colonoscopy or barium enema for diagnosis of colorectal cancer in older symptomatic patients: two multicentre randomised trials with economic evaluation (the SIGGAR trials)
2010     NIHR Health Technology Assessment programme Newer agents for blood glucose control in type 2 diabetes: systematic review and economic evaluation
2015     NIHR Health Technology Assessment programme Development of a cost-effectiveness model for optimisation of the screening interval in diabetic retinopathy screening
2014     NIHR Health Technology Assessment programme Ipilimumab for previously untreated unresectable malignant melanoma: a single technology appraisal
2018     NIHR Health Technology Assessment programme Closing five Emergency Departments in England between 2009 and 2011: the closED controlled interrupted time-series analysis
2020     NIHR Health Technology Assessment programme CARer-ADministration of as-needed sub-cutaneous medication for breakthrough symptoms in home-based dying patients: a UK study (CARiAD)
1999     NIHR Health Technology Assessment programme A systematic review of the role of human papillomavirus testing within a cervical screening programme
2003     NIHR Health Technology Assessment programme Evaluation of molecular tests for prenatal diagnosis of chromosome abnormalities
2010     NIHR Health Technology Assessment programme A randomised controlled equivalence trial to determine the effectiveness and cost utility of manual chest physiotherapy techniques in the management of exacerbations of chronic obstructive pulmonary disease (MATREX)
2010     NIHR Health Technology Assessment programme Recombinant human growth hormone for the treatment of growth disorders in children: a systematic review and economic evaluation
2011     NIHR Health Technology Assessment programme Liraglutide for the treatment of type 2 diabetes
2015     NIHR Health Technology Assessment programme Active Treatment for Idiopathic Adolescent Scoliosis (ACTIvATeS): a feasibility study
2015     NIHR Health Technology Assessment programme Pan-retinal photocoagulation and other forms of laser treatment and drug therapies for non-proliferative diabetic retinopathy: systematic review and economic evaluation
2018     NIHR Health Technology Assessment programme AVURT: aspirin versus placebo for the treatment of venous leg ulcers a Phase II pilot randomised controlled trial
2019     NIHR Health Technology Assessment programme An evaluation of the feasibility of conducting a randomised clinical trial to evaluate the clinical and cost-effectiveness of a more permissive temperature threshold for antipyretic intervention in critically ill children with fever due to infection: the FEVER feasibility study
2009     NIHR Health Technology Assessment programme Paracetamol and Ibuprofen for the treatment of fever in children: the PITCH randomised controlled trial
2010     NIHR Health Technology Assessment programme Clinical effectiveness and cost-effectiveness of stem cell transplantation in the management of acute leukaemia: a systematic review
2011     NIHR Health Technology Assessment programme Eltrombopag for the treatment of chronic idiopathic (immune) thrombocytopenic purpura
2019     NIHR Health Technology Assessment programme Interferon gamma release assays for Diagnostic Evaluation of Active tuberculosis (IDEA): test accuracy study and economic evaluation
2016     NIHR Health Technology Assessment programme PLEASANT: Preventing and Lessening Exacerbations of Asthma in School-age children Associated with a New Term a cluster randomised controlled trial and economic evaluation
2022     NIHR Health Technology Assessment programme Targeting vascular adhesion protein-1 (VAP-1) for the treatment of liver fibrosis: a study of efficacy and mechanisms in patients with primary sclerosing cholangitis (PSC)
2017     NIHR Health Technology Assessment programme Etelcalcetide for treating secondary hyperparathyroidism (ID908)
2002     NIHR Health Technology Assessment programme Screening for hepatitis C among injecting drug users and in genitourinary medicine clinics: systematic reviews of effectiveness, modelling study and national survey of current practice
2010     NIHR Health Technology Assessment programme Antenatal screening for haemoglobinopathies in primary care: a cohort study and cluster randomised trial to inform a simulation model. The Screening for Haemoglobinopathies in First Trimester (SHIFT) trial
2010     NIHR Health Technology Assessment programme Intensity-modulated radiotherapy for the treatment of prostate cancer: a systematic review and economic evaluation
2011     NIHR Health Technology Assessment programme Golimumab for the treatment of ankylosing spondylitis
2015     NIHR Health Technology Assessment programme A systematic review and individual patient data meta-analysis of prognostic factors for foot ulceration in people with diabetes: the international research collaboration for the prediction of diabetic foot ulcerations (PODUS)
2021     NIHR Health Technology Assessment programme Assistive technology and telecare to maintain independent living at home for people with dementia: the ATTILA RCT
2022     NIHR Health Technology Assessment programme Optimal utilisation of biologic drugs in Behcet's Disease: a randomised controlled trial of infliximab vs alpha interferon, with genotyping and metabolomic profiling, towards a stratified medicines approach to treatment
2018     NIHR Health Technology Assessment programme Chondroitin sulphate for hand osteoarthritis: a randomised, placebo-controlled trial in primary care: the FACTUAL STUDY
2017     NIHR Health Technology Assessment programme Eluxadoline for treating irritable bowel syndrome with diarrhoea [ID870]
2002     NIHR Health Technology Assessment programme A systematic review of the costs and effectiveness of different models of paediatric home care
2009     NIHR Health Technology Assessment programme Rapid testing for group B streptococcus during labour: a test accuracy study with evaluation of acceptability and cost-effectiveness
2011     NIHR Health Technology Assessment programme An evidence synthesis of qualitative and quantitative research on component intervention techniques, effectiveness, cost-effectiveness, equity and acceptability of different versions of health-related lifestyle advisor role in improving health
2011     NIHR Health Technology Assessment programme Retigabine for the adjunctive treatment of adults with partial onset seizures in epilepsy with and without secondary generalisation
2015     NIHR Health Technology Assessment programme Systematic review of tools to measure outcomes for young children with autism spectrum disorder
2019     NIHR Health Technology Assessment programme Early versus deferred endovenous ablation of superficial venous reflux in patients with venous ulceration: the EVRA RCT
2018     NIHR Health Technology Assessment programme Long-term weight loss following a randomised controlled trial of a weight management programme for men delivered through professional football clubs: the Football Fans in Training follow-up study
2017     NIHR Health Technology Assessment programme Cabozantinib for previously treated metastatic renal cell carcinoma [ID931]
2010     NIHR Health Technology Assessment programme BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A
2020     NIHR Health Technology Assessment programme Six versus 12 months' adjuvant trastuzumab in patients with HER2-positive early breast cancer: the PERSEPHONE non-inferiority RCT
2010     NIHR Health Technology Assessment programme Systematic review and cost effectiveness evaluation of a 'pill-in-the-pocket' strategy for paroxysmal atrial fibrillation compared to episodic in-hospital treatment or continuous antiarrhythmic drug therapy
2011     NIHR Health Technology Assessment programme Bivalirudin for the treatment of ST-segment elevation myocardial infarction
2022     NIHR Health Technology Assessment programme Allopurinol and cardiovascular outcomes in patients with ischaemic heart disease
2019     NIHR Health Technology Assessment programme Electronically delivered interventions to reduce antibiotic prescribing for respiratory infections in primary care: cluster RCT using electronic health records and cohort study
2021     NIHR Health Technology Assessment programme Impact of multiparametric MRI on staging and management of patients with suspected or confirmed ovarian cancer Short title: MR in Ovarian Cancer (MROC study)
2016     NIHR Health Technology Assessment programme Palbociclib for treating metastatic, hormone receptor-positive, HER2-negative breast cancer [ID915]
2009     NIHR Health Technology Assessment programme A prospective randomised controlled trial and economic modelling of antimicrobial silver dressings versus non-adherent control dressings for venous leg ulcers: The VULCAN trial
2013     NIHR Health Technology Assessment programme Clinical and economic evaluation of laparoscopic surgery compared with medical management for gastro-oesophageal reflux disease: 5-year follow-up of multicentre randomised trial (the REFLUX trial)
2009     NIHR Health Technology Assessment programme Antiviral drugs for the treatment of influenza: a systematic review and economic evaluation
2011     NIHR Health Technology Assessment programme Positron emission tomography (PET) and magnetic resonance imaging (MRI) for the assessment of axillary lymph node metastases in early breast cancer: systematic review and economic evaluation
2011     NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of bortezomib and thalidomide in combination regimens with an alkylating agent and a corticosteroid for the first-line treatment of multiple myeloma: a systematic review and economic evaluation
2018     NIHR Health Technology Assessment programme Enteral lactoferrin to prevent infection for very preterm infants: the ELFIN RCT
2022     NIHR Health Technology Assessment programme VIdeo assisted thoracoscopic lobectomy versus conventional Open LobEcTomy for lung cancer, a multi-centre randomised controlled trial with an internal pilot. The VIOLET Study
2021     NIHR Health Technology Assessment programme UK Cohort study to Investigate the prevention of Parastomal Hernia (CIPHER)
2015     NIHR Health Technology Assessment programme A randomised controlled trial of the clinical effectiveness and cost-effectiveness of the levonorgestrel-releasing intrauterine system in primary care against standard treatment for menorrhagia: the ECLIPSE trial